Jean Cunningham, PharmD, BCPS, indicates that ob-gyns can better identify connections between anxiety, sleep disruptions, and cognitive changes in midlife patients by considering perimenopause as a potential factor. Many patients seek explanations for such symptoms, prompting clinicians to evaluate whether they stem from hormonal transitions rather than attributing them solely to stress or the aging process.

Read More

Cunningham emphasizes the importance of assessing the timing of symptoms. For instance, clinicians should investigate whether anxiety, mood changes, or cognitive issues follow a specific pattern. It is critical to also evaluate vasomotor symptoms like hot flashes, menstrual irregularities, as well as the patient's medical history, medication usage, and life stressors. A prior history of mental health issues plays a significant role in this assessment, with ongoing research supporting its importance.

However, not every mood or cognitive symptom can be linked to hormonal changes. Screening for depression and anxiety remains essential, and safety assessments should be conducted when necessary. Cunningham advises against a binary view of symptoms as solely hormonal or psychological, highlighting the significant overlap between the two. Clinicians should remain aware of the patient's age and consider all potential contributing factors. "Treating symptoms in isolation risks overlooking the underlying cause," Cunningham notes.

When anxiety or cognitive issues arise during hormonal fluctuations, isolated treatments may not fully address the problem. While selective serotonin reuptake inhibitors may benefit some patients, solutions that also improve hormonal health can provide a broader therapeutic approach. New assessment tools currently being validated may assist clinicians in recognizing the contexts of these symptoms, validating the patient's experiences, and discussing a range of care options.

For patients in their late 30s and 40s, early identification may involve routine inquiries as part of preventive care. Questions regarding menstrual patterns—such as cycle irregularities, changes in flow, or duration—are crucial. Sleep-related questions should cover issues like nighttime awakenings, persistent thoughts, sweating, and daytime fatigue. Mood assessments should focus on new anxiety, irritability, low mood, reduced resilience, and difficulties with concentration or routine tasks. Other relevant symptoms include episodes of heat, night sweats, heart palpitations, headaches, and changes in libido or urinary issues.

Clinicians should document when changes began and whether they align with menstrual cycles or other identifiable patterns. Discussions about work, relationships, and daily functioning can also help patients articulate the external implications of their internal experiences. It is important to evaluate any history of depression, anxiety, migraines, and assess thyroid and other health conditions, as well as bone health and fracture risks during this hormonally unstable period.

Cunningham concludes by advocating for normalizing discussions around these issues and encouraging clinicians to look for patterns across menstrual, physical, sleep, and emotional symptoms.